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Abstract

Alessandro Sette, Department of Medicine,
University of California San Diego, La Jolla,
CA, United States.
Email: alex@lji.org

Background: Characterization of allergic responses to cockroach (CR), a common
aeroallergen associated with asthma, has focused mainly on IgE reactivity, but little
is known about T cell responses, particularly in children. We conducted a functional
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5UM1AI114271‐03, UM2AI117870

with asthma.
Methods: Peripheral blood mononuclear cells (PBMCs) were obtained from 71
children, with mild‐to‐moderate asthma who were enrolled in a CR immunotherapy
(IT) clinical trial, prior to treatment initiation. PBMC were stimulated with peptide
pools derived from 11 CR allergens, and CD4+ T cell responses assessed by intracellular cytokine staining.
Results: Highly heterogeneous responses in T cell reactivity were observed among
participants, both in terms of the magnitude of cytokine response and allergen
immunodominance. Reactivity against Bla g 9 and Bla g 5 was most frequent. The
phenotype of the T cell response was dominated by IL‐4 production and a Th2
polarized profile in 54.9% of participants, but IFNγ production and Th1 polarization
was observed in 25.3% of the participants. The numbers of regulatory CD4+ T cells
were also highly variable and the magnitude of effector responses and Th2 polarization were positively correlated with serum IgE levels specific to a clinical CR
extract.
Conclusions: Our results demonstrate that in children with mild‐to‐moderate
asthma, CR‐specific T cell responses display a wide range of magnitude, allergen
dominance, and polarization. These results will enable examination of whether any
of the variables measured are affected by IT and/or are predictive of clinical
outcomes.
KEYWORDS

allergens, asthma, clinical immunology, cockroach, T cell

1 | INTRODUCTION

In general, allergen‐specific T cell responses are often characterized following in vitro expansion steps17,22‐25 to account for their

Cockroach is a common allergen in urban and under‐resourced areas

low frequency which may also alter the phenotype of responding T

and a significant source of atopic morbidity worldwide, particularly

cells.26 We and others previously demonstrated that allergen‐specific

1‐3

The German cockroach (CR,

T cells can be detected ex vivo using a novel assay strategy with the

Blattella germanica) is commonly associated with CR allergies in the

combination of several T cell epitopes into pools.24,27‐29 This tech-

United States with CR allergens being detected in 85% of homes in

nique uses the upregulation of the activation markers such as CD154

low‐income urban communities.4 CR allergy has a high prevalence,

(CD40L) as a read‐out for T cell reactivity and can be combined with

and has long been established as a strong cause of asthma initiation

intracellular cytokine staining (ICS) to further identify T cell pheno-

and progression with early exposure leading to increased CR sensi-

types as well as polyfunctionality24,27,30 and to improve the charac-

among children and young adults.

4‐8

tization, asthma severity, and morbidity.

terization of CR‐specific T cell responses.

Several studies defined CR allergens based on IgE reactivity from

Thirteen groups of German CR allergens have been defined

sensitized individuals and correlated sensitization prevalence with

based on IgE reactivity and are listed at the official allergen database

severity of clinical symptoms.3,9‐12 T cells, and in particular type 2T

maintained by the World Health Organization and International

helper cells, significantly contribute to the development of allergy

Union of Immunological Societies (WHO/IUIS) Allergen Nomencla-

and asthma13‐15; however, CR‐specific T cell responses have been

ture Sub‐committee (www.allergen.org).2 As in the case of other al-

characterized in less detail,16‐21 and very little information is avail-

lergies (i.e., cat, mite, or mouse24,27,31,32), certain allergens have been

able particularly for the population most impacted by CR allergies,

described as dominant for CR‐specific T cell responses. Those studies

namely urban and under‐resourced children.

however were associated with certain limitations, such as testing a
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set of candidates derived from predicted epitopes from a more

the online supporting information. Sequences of 11 major cockroach

limited set of allergens, reliance on in vitro expansion and re‐

allergens were collected from UniProt. A strategy using 15mer

stimulation steps, and most importantly they only addressed

peptides overlapping by 10 amino acids was selected to get the full

dominance in sensitized adults.16‐18

coverage of all the allergens (Table S1). It is well established that

Here we characterized the patterns of T cell responses to 11

epitopes bind to HLA‐class II molecules through a nine residues core,

cockroach allergens in a cohort of children with CR sensitization and

and are on average 14–16 residues in overall length. The peptide

asthma with a median age of 12 years that were enrolled as potential

selection utilized in this manuscript and commonly utilized in other

participants in an IT clinical trial (CRITICAL) and before initiation of

studies relies on the fact that ensures that each 9 “core” amino acids

treatment. T cell responses for each individual allergen were

that bind to the MHC‐II groove is contained in at least one peptide.

assessed by conducting ex vivo assays directly from PBMC not pre‐

An alternative strategy would be to generate 15mers overlapping by

stimulated with CR extract using pools of overlapping peptides

14 amino acids. Although more rigorous, this strategy would signifi-

spanning the entire protein sequence of the various CR allergens. The

cantly increase the number of peptides to be generated and tested

basal numbers of regulatory CD4+ T cells (Tregs) was also assessed,

which was not feasible in light of the limited numbers of cells avail-

and compared with the magnitude of effector T cell responses.

able to study. Peptides were purchased from A & A as crude material

Additional correlation analyses were performed to examine the

on a small (1 mg) scale.

relationship of T cell responses to skin prick test and serological IgE
responses33 as well as to the Composite Asthma Severity Index
(CASI) and its components.34

2.4 | Activation Induced Marker (AIM) assay and
experimental design

2 | METHODS

Evaluations of T cell responses were based on previously described
Activation Induced Marker (AIM) ex vivo assays,30,35,36 utilizing the

2.1 | Study subjects

CD154 (CD40L) and CD137 (4‐1BB) markers, combined with intracellular cytokine staining (ICS), using the antibodies described in

This cohort is part of an ongoing clinical trial CRITICAL (Cockroach

Table S2 and performed as detailed in the online supporting infor-

Immunotherapy in Children and Adolescents; https://clinicaltrials.

mation. The cytokines IL‐4, IFNγ, and IL‐10 were included as repre-

gov/ct2/show/NCT03541187). Subjects were enrolled if they were

sentative of Th2, Th1, and Tr1/T Regulatory (Tregs) CD4 helper T cell

IgE sensitized to CR antigen (measured by skin prick testing and

subsets, respectively.24,37 The phenotypic CD127 and CD25 Tregs

serum IgE) and were ages 8 through 17 with well‐controlled asthma

markers were also included in the cytometry analysis panel30,38 and

(mild‐moderate persistent) at study entry (Table 1). Clinical charac-

the several T cell parameters determined as described in the

teristics and evaluation are detailed in the online supporting infor-

supporting information.

mation. The study was approved via a central Institutional Review
Board, the Western IRB (WIRB Tracking Number 20180698), the
DAIT NIAID and NIH/IND# 17979 (Protocol ID#: ICAC‐28). All

2.5 | Statistical analysis

participants enrolled in this study provided written consent or
provided assent with parental consent.

Comparisons between cytokine responses were performed using the
nonparametric two‐tailed, paired Wilcoxon test. Correlations between magnitude of response and polarization or between different

2.2 | PBMC isolation

cytokine production in each participant were performed using the

Peripheral blood mononuclear cells (PBMC) were isolated from

multiple comparisons was performed. Pearson correlation test was

whole blood by using CPT (cell preparation tubes) tubes according to

used to compare the two different measurements of Tregs. Prism

the manufacturer's instructions (BD Vacutainer CPT tube with

8.0.1 (GraphPad) was used for these calculations. Values pertaining

sodium heparin BD 362753, BD Biosciences) as detailed in the online

to significance and correlation coefficient (R) are noted in the

supporting information.

respective figure, and P < 0.05 defined as statistically significant.

2.3 | Measurement of IgE, IgG, and IgG4 antibody
and peptide synthesis

3 | RESULTS

Spearman's rank correlation coefficient test. No adjustment for

3.1 | Study strategy
Cockroach‐specific IgE, IgG, and IgG4 antibody levels were measured
in sera using a Thermo Fisher Scientific ImmunoCAP system (Phadia

PBMC were obtained from 71 study participants enrolled from 11

250 Immunoassay Analyzer; Thermo Fisher Scientific) as explained in

clinical sites prior to allergen IT and cryopreserved for subsequent
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Characteristics of the donor cohort

Participating
donors

Sex (%)

Demographic subgroup (%)

Total number
n = 71

54.9% M
45.1% F

Black or African American (63.4) White
(18.3) Other (18.3)

Cockroach‐specific
IgE (kUA/L)

SPT wheal sizeb
(mm)

8–17 2–8

0.12–>100

3.0–17.5

12.0

4.0

2.8

6.0

12.0

3.7

23.5

6.9

1.3

69.6

3.3

Other
variables

Age

Range
Median
Average

Std deviation 2.4

CASI
scorea

a

CASI stands for Composite Asthma Severity Index. Range of scores: 0 (least severe) to 20 (most severe) asthma.

b

SPT stands for skin prick test.

analysis (Figure 1a). To characterize the magnitude and polarization

(57‐fold). Furthermore, as shown in Figure S1b, the variation in the

of allergen responses directed against Blatella germanica (Bla g)

percent of each cytokine for the control donor was calculated for

allergens, we tested sets of overlapping peptides, spanning the entire

each repeated assay. The response accounted predominantly for IL‐4

sequence of 11 different CR allergens, using Activation Induced

cytokine secretion and, the Th2 polarization (>50% of total response)

Marker (AIM) assays,30,35,36 combined with Intracellular Cytokine

was consistently observed in all technical repeats (n = 42). Lastly, no

Staining (ICS; Figure 1b and see supporting information for more

significant difference was observed in the magnitude of response as a

detail).

function of the different clinical sites from which the subjects were

Figure 1c shows representative data for the detection of each

enrolled (Figure S1c).

cytokine. Three different donors where used for the different cyto-

Overall, IL‐4 responses across the different participants were

kine measurements. Specifically, IL‐4 response to Bla g 9, IFNγ

significantly larger than the IFNγ and IL‐10 responses, approxi-

response to Bla g 3, and IL‐10 response to Bla g 2 allergen peptide

mately 2‐fold and 4‐fold larger, respectively (Figure 2b). This was

pool stimulation. Strong cytokine production was observed in

expected as all subjects in the study cohort were diagnosed with

response to the positive control (PMA/Ion) but not in response to the

allergic asthma, and that a Th2 profile is a characteristic feature of

negative control (DMSO) or peptide pools from allergens not

allergic responses.39,40 To visualize the nature and degree of po-

recognized for a particular donor. For each participant, individual IL‐

larization as a function of each individual participant, the same data

4, IFNγ, and IL‐10 cytokine responses to each pool was summated to

were plotted in an alternative format (Figure 2c) where, for each

determine the total number of effector T cells (Teff; antigen‐specific

participant, the percent of the total response to be ascribed to each

CD154+ cells24,30).

of the three cytokines was plotted and grouped according with their
polarization profile (>50% of total response). The responses in most
participants (n = 39/71) were IL‐4 polarized (i.e., IL‐4 is the domi-

3.2 | Overall magnitude and polarization of Bla
g‐specific T cell responses

nant cytokine produced), while only 18 and 3 participants were
IFNγ and IL‐10 polarized, respectively. No clear polarization was
noted for an additional 11 participants. Interestingly, an IFNγ and

The overall magnitude of CD4+ T cell CR‐specific responses is

IL‐4 co‐dominant pattern was observed in 4 out of those 11

shown in Figure 2a, where for each participant a bar represents the

individuals.

total cytokine response for all the different allergens combined.

The data in Figure 2a indicate that the most vigorous responses

Each bar is further color coded to show which fraction of the

were also the most polarized toward IL‐4 production. Further analysis

response for each participant is accounted for IL‐4 (blue), IFNγ

(Figure 2d) found that the total magnitude (total cytokine response)

(red), or IL‐10 (green). The overall magnitude of baseline responses

correlated with Th2 (IL‐4) responses (p < 0.0001; R = 0.59) and

varied over approximately 2 logs across different subjects in the

inversely correlated with Th1 (IFNγ) and IL‐10 producing cells

study cohort (ranging from 21 to 1198 cells per million of CD4+ T

(p = 0.0009; R = −0.38 and p < 0.0001; R = −0.53, respectively).

cells).

These results suggest that stronger responses to CR allergens were

This large variation between participants was not the result of

more IL‐4 polarized, and that weaker responses were associated with

assay‐to‐assay variability, as demonstrated by specific controls uti-

IFNγ and/or IL‐10 production. Correlation between the different

lized in the assays. More specifically, in each assay, we also included a

cytokine responses in each individual participant was also analyzed.

PBMC aliquot from an adult volunteer with a moderate degree of

As shown in 2, IFNγ and IL‐10 responses were highly correlated but

cockroach allergy, who underwent apheresis to provide numerous

IL‐4 did not correlate with IFNγ or IL‐10 responses. Further corre-

cell aliquots available for use. As shown in Figure S1a, limited assay‐

lation analysis comparing the polyclonal T cell responses (PMA/Ion

to‐assay variability was observed in repeated assays (n = 42) from

stimulation) and CR‐specific T cell responses was performed. As

the lowest to the highest response in the 3.3‐fold range, which is far

shown in Figure S3, CR‐specific immune responses in this study do not

less variable than variability observed within the participant cohort

reflect the general immune responses at the individual donor level.
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F I G U R E 1 Study design and experimental strategy. (A) A total of n = 71 subjects were enrolled from 11 clinical sites, and blood samples
were collected and PBMC isolated and cryopreserved. (B) PBMC were tested against a set of peptide pools consisting of overlapping peptides
spanning the entire sequence of 11 different CR allergens, and T cell cytokine responses assessed by a combination of the Activation Induced
Marker (AIM) and Intracellular Cytokine Staining (ICS) assays after 6 h of stimulation. (C) Dot plots depict the cytokine detection of IL‐4, IFNγ,
and IL‐10 in CD154+ CD4+ T cells after stimulation with DMSO, PMA/Ion or sets of peptide pools for a given allergen. Three different donors
are shown to illustrate the measurements of IL‐4, IFNγ, and IL‐10 cytokine secretion to a particular high‐reactive CR allergen and the absence
of response to a particular CR allergen as control. Specific allergen tested in each condition is indicated in dot‐plots as well as the frequency of
CD154+ cytokine + events of total CD4+ T cells

Lastly, in these experiments, we also included a previously
described megapool of Bordetella pertussis (BP) epitopes.

41

Children in

suggesting that there are factors determining the degree of Th2
polarization that are antigen/allergen‐specific.

our cohort, based on their year of birth, are expected to have been
vaccinated with the acellular pertussis (aP) vaccine which is associated with a predominantly Th2 response.42,43 As expected, and
shown in Figure S4a, BP responses in this cohort were Th2 polarized,

3.3 | Bla g 9 and Bla g 5 are the most dominant
allergens for T cell responses

with a median ratio of IL‐4/IFNγ cytokine response of 2.5 and
significant participant‐to‐participant variability. The degree of Th2

Previous studies established that certain allergens are immunodo-

polarization observed in the BP responses did not correlate with the

minant (i.e., account for a larger fraction of the total response)17,24,44

degree of polarization observed in the CR responses (Figure S4b),

at the population level. However, more granular analyses also

6 of 12
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F I G U R E 2 Baseline cytokine responses of CD154+ cells are IL‐4 polarized and correlate with magnitude of responses. (A) Graph bars
show the overall magnitude of CD4+ T cell CR‐specific responses as the sum of the 11 individual allergens tested. Each bar represents a
participant (n = 71) and the fraction of the response accounted for each cytokine (IL‐4 (blue), IFNγ (red), or IL‐10 (green)). (B) Graph compares
the IL‐4, IFNγ and IL‐10 allergen responses for all the individual participants combined. Geometric mean and p value are shown as statistically
significant by Wilcoxon's paired t‐test. (C) Graphs depict the percentage of each individual cytokine contribution from total response, grouped
as function of the IL‐4, IFNγ, IL‐10 dominant (>50% of total response) or non‐dominant cytokine profile for a particular participant. Each dot
and interconnected lines represents a participant and the number of participants in each group is shown. (D) Graphs show the correlation of
total cytokine response with the relative IL‐4, IFNγ and IL‐10 cytokine response. R values and p values are shown as statistically significant by
nonparametric Spearman correlation test and best fit represented by a linear regression line (red)

established that individual patterns of immunodominance are also

considering the individual types of immune responses Bla g 9 was by

detected, and the immunodominant antigens can vary from one in-

large the most dominant allergen of IL‐4 responses (52.1%), and Bla g

dividual to the next.10,11,16

3 (16.0%) or Bla g 2 (14.5%) the most dominant allergens of IFNγ and

Accordingly, we first established which specific CR allergens

IL‐10 cytokine responses, respectively (Figure 3a and Figure S5).

would be dominant for T cell responses in the cohort of allergic

Next, the data were analyzed at a higher level of granularity to

CR‐sensitized children. Figure 3a shows the overall response

investigate which antigens would be more dominantly recognized for

directed against each allergen, calculated by summing, separately for

each of the subjects tested, and each participant was assigned to

each individual allergen, the responses observed in each individual

different immunodominance categories. In terms of total cytokine

participant. The Bla g 9 and Bla g 5 allergens were the most domi-

response (Figure 3b), a total of 19 participants recognized the Bla g 9

nant, accounting for 38.8% and 11.1% of the total response. Other

allergen as most dominant, while Bla g 5 was most dominant in 7

allergens were also recognized, albeit to a lower extent. When

participants. Bla g 3 and Bla g 7 were dominant in 4 participants, and
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Bla g six in 3 participants. The other allergens were dominant in one

markers CD4+CD25 + CD127low38,45 (Figure 4a and 4b). There was

and two participants each or none, and patterns of co‐dominance or

substantial variation in the number of Tregs (total CD137+) among

no clear pattern of dominance were detected for 28 participants

participants (Figure 4c), the number of CD137+ cells varing 90‐fold

(Figure 3b).

from 925 to 86,000 per million CD4+ T cells.
We hypothesized that the size of the baseline Treg population
present in each individual might influence their capacity to mount an

3.4 | Detection of basal levels of regulatory T cells

allergen‐specific T cell response following stimulation with the
allergen‐derived peptide pools. There was a suggestion of an inverse

In the next series of experiments, we analyzed the number of Tregs at

correlation between the number of Tregs (CD137+ unstimulated

baseline in the absence of antigen stimulation. We defined baseline

cells) and the number of Teff (cytokine + CD154+ allergen‐

Tregs as the total number of CD137 + CD154‐ T cells detected at

stimulated

baseline, without any antigen stimulation.30 As expected, Tregs defined

(Figure 4d). We further observed to be the case in patients with IL‐4

as CD137+ were correlated with Tregs defined by the alternative

but not IFNγ dominant responses (Figure S6).

cells),

but

this

was

not

statistically

significant

F I G U R E 3 Bla g 9 and Bla g 5 are the most immunodominant allergens and dominance is participant specific. (A) Graph shows the overall
response directed against the 11 allergens tested, calculated by summing each individual allergen response for all participants. Each bar
represents an allergen and the fraction of the response accounted for each cytokine (IL‐4 [blue], IFNγ [red], or IL‐10 [green]). Table depicts the
percentage of total or individual cytokine responses for each allergen. (B) Graphs show for each individual participant (dots and
interconnected lines) the fraction of the response accounted for each allergen and grouped as a function of allergen immunodominance (‐high)
or lack of dominance. Bla g 1 and Chitinase not shown in graphs as no dominant responses were observed. The number of participants
associated with each category is shown

8 of 12
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3.5 | Correlation of T cell responses with sera
antibody titers to CR extract, SPT responses, and
clinical presentation
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IgE/IgG4 ratios. In addition, as shown in Table 2, the total magnitude
of responses positively correlated with IgE titers or the IgE/IgG4
ratios (p = 0.0082; R = 0.31 and p = 0.0071; R = 0.32, respectively),
and no associations were observed for Treg frequencies.

We also tested whether T cell responses were associated with IgE,

We next examined the correlation of T cell responses with the

IgG, and IgG4 titers specific for CR as well as with the ratio between

results of a skin prick test (SPT) specific for extracts of German and

IgE/IgG4 responses. The results summarizing these analyses

American CR, which share homologous allergens (www.allergen.org).

are shown in Table 2. A significant correlation was observed between

As shown in Table S3, total responses or IL‐4 responses were posi-

IL‐4 responses or IL‐4 (Th2) polarization and IgE levels (p = 0.0003;

tively but weakly correlated (p = 0.035; R = 0.25 and p = 0.042;

R = 0.42 and p < 0.0001; R = 0.45, respectively) and to a less extent

R = 0.35, respectively), while IL‐10 polarization was negatively

with total IgG but not IgG4. Conversely, IFNγ (Th1) and IL‐10

correlated (p = 0.015; R = −0.29) with the mean wheal diameter

polarization showed an inverse correlation with the IgE titers

(MWD) of the SPT for the American CR extract. Conversely, none of

(p = 0.0044; R = −0.33 and p = 0.0013; R = −0.37, respectively).

the T cell variables correlated with MWD of the SPT for the German

The same results were noted in regards to the correlation with the

CR extract (Table S3). Despite differences in the source of the CR

F I G U R E 4 Treg numbers varies amongst participants and are inversely correlated with Teff responses. (A) Dot plots show a
representative participant for the Treg gating strategy. (B) Graph show the correlation of total CD137+ cells and CD25 + CD127low CD137+
cells in unstimulated cells by Pearson correlation test. (C) Graph bars show the number of Tregs (CD137+ cells) across all participants (n = 71).
Figure insert depicts 2 representative participants with High or Low Treg populations, respectively. (D) Graph shows the correlation of Tregs
(Total CD137+ unstimulated cells) and Teff (cytokine + CD154+ allergen‐stimulated) cells by nonparametric Spearman correlation test. For
both correlation graphics, each dot represents a participant (n = 71). R values and p values are shown and best fit represented by a linear
regression line (red)
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extract considered, these results confirm the associations noted at

particular, we found over 57‐fold variation in magnitude of allergen‐

the serological level.

specific T cell responses. The more vigorous responses were also the

Lastly, we examined correlations of the T cell variables (magni-

most Th2 polarized and while the allergens Bla g 9 and Bla g 5 were

tude, polarization, or dominance of specific allergens) with clinical

most immunodominant, individual subjects exhibited distinctive

variables such as those captured by Composite Asthma Severity In-

patterns of allergen dominance. Subjects with higher magnitude of

dex (CASI) score and components.34 As shown in Table S4, none of

allergen‐specific T cell reactivity had lower number of Treg

the T cell immunological variables correlate with the total CASI score.

populations. Overall, this study unveils a surprisingly high level of

Also, no differences were observed in clinical symptoms between

heterogeneity in the pattern of Bla g‐specific T cell reactivity, both

patients with IL‐4 or IFNγ dominant responses (Figure S7). These

quantitatively and qualitatively. Since the cohort analyzed is enrolled

results were not unexpected given the fact that this cohort was

in a future IT clinical trial, this finding lays the foundation for

designed to encompass relatively homogeneous CASI scores, ranging

examining whether this heterogeneity may potentially correlate with

from low to medium severity (median CASI of 4).

IT outcomes.
This study is to the best of our knowledge, the first characterization of ex vivo CR‐specific CD4+ T cell responses in CR‐sensitized

4 | DISCUSSION

urban and under‐resourced children with asthma, and for the majority of the known CR allergens to date, which are also components

Here we report the direct ex vivo characterization of T cell responses

commonly found in CR extracts used for IT.2,10 Our results also differ

to a panel of 11 previously described CR allergens in a cohort of CR

from previous attempts of portrayal of CR‐specific responses,17,19,20

allergic children and adolescents with well‐controlled asthma. In

because of the high level of granularity and because the ex vivo

T A B L E 2 Correlation of T cell
responses with cockroach (CR)‐extract
specific titers

Spearman r

IgE Ext (RUa)

IgG Ext (RUa)

IgG4 Ext (RUa)

Ratio IgE/IgG4

Total magnitude of responses (CD154)
R

0.31

0.15

0.14

0.32

P value

0.0082

0.2125

0.2542

0.0071

IL‐4 responses (CD154)
R

0.42

0.2

0.12

0.43

P value

0.0003

0.0965

0.3141

0.0002

0.26

0.12

0.43

0.0301

0.3378

0.0002

IL‐4 (Th2) polarization
R
P value

0.45
<0.0001

IFNγ responses (CD154)
R
P value

−0.1
0.3952

−0.13
0.2704

0.07
0.5647

−0.1
0.398

IFNγ (Th1) polarization
R
P value

−0.33
0.0044

−0.26
0.0263

−0.085
0.4784

−0.33
0.0047

IL‐10 responses (CD154)
R
P value

−0.18
0.1328

13
0.2979

−0.00099
0.9935

−0.2
0.096

IL‐10 polarization
R
P value

−0.37
0.0013

−0.18
0.1347

−0.099
0.411

−0.41
0.0003

Treg baseline numbers
R
P value
a

−0.11
0.3729

RU stands for relative units.

−0.15
0.2209

−0.062
0.6047

−0.093
0.4384
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approach allowed to characterize responding cells to a minimal gap

and this raises the possibility that Bla g 9 recognition could be a

from bona fide in vivo responses.

pattern predominantly associated with childhood CR allergy.

We identified a large dynamic range in terms of magnitude of

This pattern of immunodominance has been observed in subjects

CD4+ T cell responses, despite the narrow age range and similar

from the different clinical sites, irrespective of geographical location,

clinical manifestations of disease among participants. Positive con-

further suggesting that Bla g 5 and Bla g 9 responses to CR are

trols included in each assay excluded that this was due to inter‐assay

intrinsic to this particular age cohort. Changes in the IgE pattern of

variability. The assessment of the variation of PBMC from the same

reactivity to individual Timothy grass and birch pollen allergens were

subjects taken at different time points would have also been of great

observed over the course of 20 years for sensitized individuals.54

interest but limited by the number of existing cells available to

Future studies could examine whether changes in allergen immuno-

perform the tests. Nevertheless, this should be considered in future

dominance are apparent as a function of age and exposure history.

study designs. Likewise, the variability was not explained by differ-

The pattern of reactivity as a function of the specific subject

ential responses as a function of the different clinical sites from

considered was also heterogeneous with different individuals

which each subject was enrolled. A high spread in the magnitude of T

recognizing either Bla g 9 or Bla g 5 as dominant, with dominant

cell responses has been previously described for other allergic re-

responses to other allergens or no pattern of dominance also

sponses, namely to cat dander, fungus, mite and grass or birch

observed. Individual immunodominance patterns were observed in

pollen30,46,47 using ex vivo methodologies similar to our study. It is

adult cohorts16 and for IgE reactivity.55 Different HLA could influ-

possible that the ex vivo assay strategy utilized contributed to reveal

ence allergen immunodominance. Associations between CR sensiti-

this heterogeneity, as previous allergy studies in the case of

zation and HLA class II antigens have been suggested56,57 and

CR16,18,20 or other allergens24,27 utilized in vitro restimulation

consistently shown in food allergies.58,59

protocols which might obscure and blunt differences.

In addition, we measured basal levels of non‐antigen specific

We also analyzed the functionality of CD4+ T cell responses,

regulatory T cells and observed that T cells inversely correlated

which was dominated by IL‐4 production and a Th2 polarization

with the effector CD4+ T cell responses although it did not reach

profile. Development of early allergic disease seems to be related to

statistical significance. These results were not unexpected and were

48

and previous

consistent with previous observations from Bacher et al.30. The fact

studies have also demonstrated that levels of Th2 cytokines such as

that the population of Treg cells varies amongst participants is also

IL‐4, IL‐5, and IL‐13 are associated with pathogenesis of both allergy

of potential interest, as this will enable monitoring of Treg and

and asthma.13‐15 In our study, Th2 polarization was the dominant

addressing whether baseline Treg levels predicts response to IT. A

phenotype but other patterns were also observed. The accuracy of

possible outcome is that IT may induce or enhance regulatory T cell

this characterization was confirmed with a positive control included

function, which can be further tested. Indeed, peanut oral immu-

in each assay. In particular, while IL‐10 responses were rare, a profile

notherapy has been shown to increase antigen‐induced Treg

of IFNγ production or Th1 polarization was observed in one‐fourth of

function.60

sustained Th2‐skewed immunity during childhood

the participants and associated with weaker T cell CR‐specific re-

Overall, the current study reveals that in a pediatric cohort of

sponses. Also, since IFNγ is thought to be secreted in higher amounts

CR‐sensitized subjects with mild‐to‐moderate asthma, subjects

per cell than IL‐4, perhaps the actual net amount of cytokine pro-

exhibit substantial heterogeneity in many key immunological pa-

duction might not necessarily correlate with the number of cytokine

rameters associated with CR‐specific T cell responses. We hypothe-

secreting cells as determined herein, but additional studies would be

size that this large dynamic range of T cell reactivity may influence

needed to clarify this conjecture. Interestingly, resolution of allergic‐

outcomes of allergen‐specific IT. These findings will also enable

related immunopathologies is often also attributed to increase of

future research examining which of these parameters best predict

IFNγ levels rather than reduction of Th2‐cytokine production,49 and

the trajectory of evolution of allergic disease, and responsiveness to

IL‐10 is found to regulate CD4+ Th2 cells during allergic airway

therapeutic intervention.

inflammation.50 Therefore, the close monitoring of both IL‐10 and
IFNγ cytokines would be of interest in the context of IT and could
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